Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Among authors: lowenberg m. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Biosimilars in IBD: hope or expectation?
Gecse KB, Khanna R, van den Brink GR, Ponsioen CY, Löwenberg M, Jairath V, Travis SP, Sandborn WJ, Feagan BG, D'Haens GR. Gecse KB, et al. Among authors: lowenberg m. Gut. 2013 Jun;62(6):803-7. doi: 10.1136/gutjnl-2012-303824. Epub 2013 Mar 16. Gut. 2013. PMID: 23503043 Review. No abstract available.
Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease.
Brandse JF, Peters CP, Gecse KB, Eshuis EJ, Jansen JM, Tuynman HA, Löwenberg M, Ponsioen CY, van den Brink GR, DʼHaens GR; North Holland GUT Club. Brandse JF, et al. Among authors: lowenberg m. Inflamm Bowel Dis. 2014 Feb;20(2):251-8. doi: 10.1097/01.MIB.0000438248.14218.1d. Inflamm Bowel Dis. 2014. PMID: 24378599 Clinical Trial.
Impact of disease location on fecal calprotectin levels in Crohn's disease.
Gecse KB, Brandse JF, van Wilpe S, Löwenberg M, Ponsioen C, van den Brink G, D'Haens G. Gecse KB, et al. Among authors: lowenberg m. Scand J Gastroenterol. 2015 Jul;50(7):841-7. doi: 10.3109/00365521.2015.1008035. Epub 2015 Jan 30. Scand J Gastroenterol. 2015. PMID: 25636819
172 results